Clinical trial
Systemic Immunomodulatory Effects and Pharmacogenetics of Atorvastatin in Early…
NCT00361283 · University of Florida, Other · Completed
Key facts
| NCT number | NCT00361283 |
|---|---|
| Title | Systemic Immunomodulatory Effects and Pharmacogenetics of Atorvastatin in Early Atherosclerosis |
| Official title | Systemic Immunomodulatory Effects and Pharmacogenetics of Atorvastatin in Early Atherosclerosis |
| Lead sponsor | University of Florida, Other |
| Collaborators | American Heart Association American College of Clinical Pharmacy |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Inflammation |
| Intervention type | Drug |
| Interventions | Atorvastatin |
| Enrollment | 108 |
| Start date | Jun 1, 2004 |
| Primary completion | Dec 1, 2008 |
| Completion | Jan 1, 2009 |
| First posted | Aug 8, 2006 |
| Last update posted | May 15, 2012 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: